We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
More than a dozen states are considering drug price transparency bills — most recently in California, where a state senate committee voted to advance legislation requiring drugmakers to disclose operating costs. Read More